Computerised tomogram head abnormal and Weakness

Summary:

Weakness is found among people with Computerised tomogram head abnormal, especially for people who are female, 50-59 old.

The study analyzes which people have Weakness with Computerised tomogram head abnormal. It is created by eHealthMe based on reports of 17 people who have Computerised tomogram head abnormal from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Computerised tomogram head abnormal?

Computerised tomogram head abnormal is found to be associated with 24 drugs and 57 conditions by eHealthMe. Check the latest studies of Computerised tomogram head abnormal.

What is Weakness?

Weakness is found to be associated with 3,641 drugs and 6,606 conditions by eHealthMe. Check the latest studies of Weakness.

On Jun, 18, 2026

17 people who have Computerised Tomogram Head Abnormal and Weakness are studied.

Would you have Weakness when you have Computerised tomogram head abnormal?

Gender of people who have Computerised Tomogram Head Abnormal and experienced Weakness *:

female: 70.59 %
male: 29.41 %

Age of people who have Computerised Tomogram Head Abnormal and experienced Weakness *:

Common co-existing conditions for these people *:

Nuclear Magnetic Resonance Imaging Brain: 5 people, 29.41%
Nuclear Magnetic Resonance Imaging Abdominal: 5 people, 29.41%
Computerised Tomogram Abdomen: 5 people, 29.41%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 11.76%
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 2 people, 11.76%
Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 2 people, 11.76%
Rashes (redness): 1 person, 5.88%
Pain In Extremity: 1 person, 5.88%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 1 person, 5.88%
Intracranial Aneurysm (bulging, weak area in the wall of a cranial artery): 1 person, 5.88%

Common drugs taken by these people *:

Common symptoms for these people *:

Skin Hypertrophy (skin cells enlarges): 9 people, 52.94%
Rashes (redness): 9 people, 52.94%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 9 people, 52.94%
Oedema Peripheral (superficial swelling): 9 people, 52.94%
Pain: 9 people, 52.94%
Skin Induration (an abnormally hard spot or area on the skin): 9 people, 52.94%
Joint Stiffness: 9 people, 52.94%
Joint Range Of Motion Decreased (disease of joint movement): 9 people, 52.94%
Scar: 8 people, 47.06%
Joint Pain: 8 people, 47.06%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weakness?

- Check whether Weakness is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Computerised tomogram head abnormal (99 reports)
Weakness (586,875 reports)

All the drugs that are associated with Weakness:

Weakness (3,641 drugs)

All the conditions that are associated with Weakness:

Weakness (6,606 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weakness and Computerised tomogram head abnormal, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.